Positron Emission Tomography (PET) radiotracers in oncology – utility of 18F-Fluoro-deoxy-glucose (FDG)-PET in the management of patients with non-small-cell lung cancer (NSCLC)

doi:10.1186/1756-9966-27-52

Journal of Experimental & Clinical Cancer Research

Volume 27

Viewing options:

Abstract
Full text
PDF (371KB)

Associated material:

Related literature:

Articles citing this article
on Google Scholar
on ISI Web of Science
on PubMed Central
Other articles by authors
on Google Scholar

Miele E
Spinelli GP
Tomao F
Zullo A
De Marinis F
Pasciuti G
Rossi L
Zoratto F
Tomao S

on PubMed

Miele E
Spinelli GP
Tomao F
Zullo A
De Marinis F
Pasciuti G
Rossi L
Zoratto F
Tomao S
Related articles/pages
on Google

on Google Scholar

on PubMed

Tools:

Post to:

Review

Positron Emission Tomography (PET) radiotracers in oncology – utility of 18F-Fluoro-deoxy-glucose (FDG)-PET in the management of patients with non-small-cell lung cancer (NSCLC)

Evelina Miele¹^,4 , Gian Paolo Spinelli¹^,2^,4 , Federica Tomao¹^,4 , Angelo Zullo³^,4 , Filippo De Marinis³^,4 , Giulia Pasciuti²^,4 , Luigi Rossi²^,4 , Federica Zoratto²^,4 and Silverio Tomao¹^,2^,4

¹Department of Experimental Medicine University of Rome "Sapienza" viale Regina Elena 324, Rome, Italy

²Operative Unit of Medical Oncology, S. Maria Goretti Hospital, University of Rome "Sapienza" – Latina-via Canova, Latina, Italy

³Gastroenterology and Digestive Endoscopy, "Nuovo Regina Margherita" Hospital, Rome 00153, Italy

⁴Thoracic Oncology Unit I, Department of Lung Diseases, San Camillo and Forlanini Hospitals, Rome, Italy

author email corresponding author email

Journal of Experimental & Clinical Cancer Research 2008, 27:52doi:10.1186/1756-9966-27-52


Published:	17 October 2008

Abstract

PET (Positron Emission Tomography) is a nuclear medicine imaging method, frequently used in oncology during the last years. It is a non-invasive technique that provides quantitative in vivo assessment of physiological and biological phenomena. PET has found its application in common practice for the management of various cancers.

Lung cancer is the most common cause of death for cancer in western countries.

This review focuses on radiotracers used for PET scan with particular attention to Non Small Cell Lung Cancer diagnosis, staging, response to treatment and follow-up